Facebook (FB) Tops Q3 EPS by 3c

Go back to Facebook (FB) Tops Q3 EPS by 3c

Facebook (FB) Price Target Lowered to $90 at FBN; Analyst Maintains Outperform Rating

October 29, 2014 9:34 AM EDT

FBN Securities maintained an Outperform rating on Facebook (NASDAQ: FB) with a price target of $90.00 (from $95.00). The change follows Q3 results. Analyst Shebly Seyrafi noted concerns about expense growth in 2015, but he views Q3 as a strong quarter and remains bullish on the stock.

"The company reported a strong quarter with almost 60% Y/Y revenue growth and improving engagement... More

Goldman Sachs Comments on Facebook's (FB) Q3 and Guidance

October 29, 2014 7:04 AM EDT

Goldman Sachs reiterated a Buy rating on Facebook (NASDAQ: FB) with a price target of $85. The stock declined yesterday during its earnings call.

Analyst Heather Bellini said, "Given the registration of the WhatsApp shares, FB offered its first and likely last... More

Cowen Lowers Target on Facebook (FB) to $86; Expenses Tighten as Company Enters Investment Cycle

October 29, 2014 6:07 AM EDT

Cowen and Company lowers its price target on Facebook (Nasdaq: FB) from $90 to $86 and maintains an Outperform rating on the stock following Q3 results.

Analyst John Blackledge noted the following points:

3Q14 Results: Financials Slightly Above Forecast; Users/Engagement Solid

FB delivered revenue of $3.20BN, +59% y/y, 2% and 3% above our and consensus' est. Adv revenue of $2.96BN, +65% y/y and 2% above our and consensus' forecast. 3Q14 Opex was 6% above our estimates, led by higher R&D and G&A. Adj. EBITDA was $2.1BN (+63% y/y) and 1% above our and consensus' forecast, implying. EBITDA... More

Facebook (FB) Tops Q3 EPS by 3c

October 28, 2014 4:02 PM EDT

Facebook (NASDAQ: FB) reported Q3 EPS of $0.43, $0.03 better than the analyst estimate of $0.40. Revenue for the quarter came in at $3.2 billion versus the consensus estimate of $3.11 billion.

Third Quarter 2014 Operational Highlights

Daily active users (DAUs) were 864 million on average for September... More